Why the price of Inspire is really three bills plus a device
An implant episode produces separate claims from the surgeon, the facility and the anesthesia team. The device charge sits inside the facility bill, and it is the least transparent part.
The 2022 study in the Journal of Clinical Sleep Medicine looked for the hypoglossal nerve stimulator in the price transparency files that federal rules require hospitals to post. Of the 111 top-ranked ear, nose and throat hospitals it checked, only 9, or 8.1 percent, disclosed a payer-negotiated price for the device. Those prices ran from $28,178 to $60,845 against a manufacturer price the authors estimated at $23,100, a median markup of $20,292, or 87.8 percent. Inside a single hospital, the highest negotiated price was on average twice the lowest, which means two patients in the same operating room with different insurers can carry very different device charges. The device is billed with the implant under CPT 64582, which describes open implantation of the hypoglossal nerve stimulator array, the pulse generator and the distal respiratory sensor electrode. Around it sit the surgeon's professional fee, the anesthesia professional fee and the facility fee, and the facility type matters. Sleep Foundation's Medicare estimates show why: it puts the average out-of-pocket cost at $5,330 when the surgery is done in an outpatient surgical center and $1,839 in a hospital outpatient department, because the hospital copay is capped and the surgical center coinsurance is not.
What Medicare actually pays, and what the patient owes
In 2018 Medicare paid $28,367 per procedure. The patient's share is the Part B deductible plus 20 percent coinsurance, with a copay cap when the surgery is done in a hospital outpatient department.
The JAMA Otolaryngology analysis of 2015 to 2018 Medicare data reported that Medicare payment for hypoglossal nerve stimulator placement totaled $28,367 per procedure in 2018, made up of $27,700 in hospital fees and $667 in physician fees. The authors estimated that manufacturer markup accounted for roughly two-thirds of that total, $18,743 or 66.1 percent. For 2026 the Centers for Medicare & Medicaid Services set the Part B annual deductible at $283, the standard Part B premium at $202.90 a month and the Part A inpatient deductible at $1,736. The last number matters for an outpatient implant because Medicare.gov states that for hospital outpatient services, in most cases, the copayment cannot be more than the Part A hospital stay deductible for each service. The exception is a critical access hospital, where the copayment may exceed it. The patient also owes 20 percent of the Medicare-approved amount for the surgeon's and anesthesiologist's services. A Medigap plan may pay some or all of that share, and a Medicare Advantage plan replaces this arithmetic with its own copay schedule.
The Medicare coverage criteria that apply in New Jersey
Novitas Solutions, the Medicare contractor for New Jersey and Pennsylvania, publishes Local Coverage Determination L38385. Every criterion has to be met and documented before the claim is paid.
The LCD states that hypoglossal nerve stimulation is reasonable and necessary when all of the following are met: the beneficiary is 22 years of age or older; body mass index is less than 35 kg/m2; a polysomnography is performed within 24 months of first consultation; the beneficiary has predominantly obstructive events, defined as central and mixed apneas less than 25 percent of the total AHI; the AHI is 15 to 65 events per hour; there is documented CPAP failure, defined as an AHI greater than 15 despite CPAP usage, or CPAP intolerance, defined as less than 4 hours per night, 5 nights per week, or the CPAP has been returned; drug-induced sleep endoscopy shows absence of complete concentric collapse at the soft palate level; and there are no other anatomical findings that would compromise performance of the device, such as tonsil size 3 or 4. The other Medicare contractors publish the same framework under their own numbers, including CGS L38307, revised effective March 5, 2026, so a patient who moves keeps the same rules. Medicare's companion billing article requires the claim to carry the obstructive sleep apnea diagnosis code G47.33 together with a Z68 code documenting a BMI under 35. Inspire's own coverage page states the same Medicare BMI limit.
Why the FDA label is wider than most coverage rules
Since June 9, 2023 the label allows an AHI up to 100 events per hour and carries a BMI warning at 40. Medicare's contractors still stop at an AHI of 65 and a BMI under 35.
Inspire Medical Systems announced on June 9, 2023 that the FDA had approved an increase in the upper limit of the apnea-hypopnea index to 100 events per hour from 65 and had raised the body mass index warning in the labeling to 40 from 32, citing data from the company's ADHERE registry. Payers moved at different speeds. Aetna's Clinical Policy Bulletin 0004 now considers the implant medically necessary at age 18 or older, BMI under 40 and AHI 15 to 100, with at least one month of documented CPAP failure or intolerance. The Medicare LCDs, including Novitas L38385 and the CGS version revised in March 2026, kept 22 years, BMI under 35 and AHI 15 to 65. Inspire's coverage page reflects the split, stating a BMI of 40 or less generally and a BMI of less than 35 for Medicare. In practice that means a person with an AHI of 70 or a BMI of 37 can be inside the label and inside a commercial policy while outside Medicare's rule. Whether any of those thresholds fit a particular person is a clinical question, and our candidacy guide explains the gates an implant evaluation checks.
What prior authorization asks for
Expect the implant center to submit the sleep study, the CPAP machine's compliance download, the drug-induced sleep endoscopy report and a documented BMI. The payer checks each against its written criteria.
Inspire's coverage page says prior authorization may be required, and both the Medicare LCD and the Aetna policy read like a document list. The sleep study has to be a polysomnogram within 24 months that reports the AHI and the share of central and mixed events. The CPAP record has to show failure or intolerance in the payer's terms: an AHI above 15 despite use, or machine-derived compliance reporting of under 4 hours a night on 5 nights a week, or a returned machine. The CGS version of the Medicare rule adds that the intolerance has to be documented alongside shared decision making with the patient. Aetna wants at least one month of documented CPAP attempts. The DISE report has to state the collapse pattern at the soft palate and the tonsil grade, and the BMI has to be on file with a matching Z68 code. Those CPAP numbers are the same 4-hour and 70-percent-of-nights thresholds Medicare uses to decide whether it keeps paying for a CPAP machine, which our CPAP compliance guide explains. A denial is usually a missing document, not a final answer, and payers publish an appeal path.
The costs that come after the surgery
Activation, programming visits, any follow-up sleep study and eventual battery replacement are separate claims in the years after the implant.
Inspire describes the implant as an outpatient procedure through two small incisions, with the device turned on at a follow-up visit rather than in the operating room. Programming and titration visits follow, and clinicians commonly order a sleep study on therapy to confirm the settings. Each of those is billed on its own. The company states that the battery is designed to last for approximately 10 years. When it runs down, the generator is replaced in a second procedure, coded CPT 64583 for revision or replacement, and CPT 64584 covers removal. That replacement lands in a future plan year with that year's deductible and coinsurance, and the public policies cited on this page address the initial implant, so ask the insurer in writing how it handles replacement. Inspire also notes that MRI eligibility depends on the model implanted: the 3028 and 3150 generators are MRI eligible under conditions, and the older 3024 is not. That is a care question rather than a cost question, but it belongs in the same pre-surgery conversation.
What to ask the implant center's financial counselor before you schedule
Six questions turn the public figures on this page into your own numbers.
First, which CPT codes will be billed and by whom, and are the surgeon, the facility and the anesthesia group all in your plan's network. Second, is the facility a hospital outpatient department or a freestanding surgical center, because the Medicare copay cap applies to one and not the other, and commercial coinsurance can differ between them too. Third, what is the negotiated device price for your insurer in the hospital's price transparency file, which the hospital is required to post. Fourth, has prior authorization been approved in writing, for which codes, and for how long is the approval valid. Fifth, how are DISE, activation, programming visits and the follow-up sleep study covered, since each is a separate claim. Sixth, what will the plan expect you to pay for generator replacement in about 10 years. The 2025 claims analysis found that neurostimulation procedures had a lower rate of potential surprise bills than other ear, nose and throat operations, 3.9 percent against 5.2 percent, but the way to bring that to zero is to confirm network status for all three billing parties before the date is set.
What this page is and is not
It is a guide to the public cost and coverage record for hypoglossal nerve stimulation. It is not a quote, a coverage decision, a candidacy assessment, or a comparison of Inspire with CPAP.
Modern Sleep & Metabolic Institute does not implant Inspire, does not quote prices for any procedure and cannot verify anyone's benefits. Whether hypoglossal nerve stimulation fits a given person is a clinical decision that belongs to the treating sleep physician and the implant surgeon, and nothing here diagnoses sleep apnea or says which treatment is better for anyone. Our candidacy guide describes the gates an implant evaluation checks. If you want a clinician for the sleep questions this page raises, our Find care page explains what is open right now: general inquiries are open, and patient matching is not open yet. That page carries a general inquiry form only. It does not collect symptoms, medications, insurance details or sleep study results, and it should not be used to send them.
Appointment checklist
What to bring to a coverage conversation
Each item answers a line in the Medicare LCD or the commercial policy quoted above. Arriving with them tends to shorten prior authorization rather than start it over.
- 1
The full sleep study report
The polysomnogram from the last 24 months, showing the study date, the apnea-hypopnea index and the share of central and mixed events, not a summary letter.
- 2
The CPAP compliance download or return receipt
Machine-derived data covering hours per night and nights used over at least 30 days, or proof the machine was returned, plus the clinician's note on failure or intolerance.
- 3
The drug-induced sleep endoscopy report
Stating the collapse pattern at the soft palate and the tonsil grade, since both are named in the coverage criteria.
- 4
Your plan's policy and authorization record
The insurer's written hypoglossal nerve stimulation policy, the prior authorization number and codes if one exists, and the network status of the surgeon, the facility and the anesthesia group.
Common questions
Questions patients ask first
Does Medicare cover Inspire?
Yes, when the criteria in the contractor's Local Coverage Determination are met and documented. In New Jersey that is Novitas Solutions LCD L38385: age 22 or older, BMI under 35, AHI 15 to 65 on a polysomnogram within 24 months, central and mixed events under 25 percent, documented CPAP failure or intolerance, and no complete concentric collapse on DISE. Part B then pays 80 percent of the approved amount after the $283 deductible, with the hospital outpatient copay capped at $1,736 in 2026.
Does Medicare Advantage cover Inspire?
A Medicare Advantage plan has to cover what Traditional Medicare covers, so the same clinical criteria apply, but the plan sets its own copays, prior authorization process and network. Ask the plan for its hypoglossal nerve stimulation policy in writing and confirm the implant center is in network.
Does Medicaid cover Inspire?
Medicaid coverage is decided state by state and plan by plan, and this page does not cite a published New Jersey Medicaid criteria document because we could not verify one. Ask the implant center to request a written coverage determination from the specific plan before scheduling any part of the workup.
How much does Inspire cost without insurance?
The most complete public figures are Medicare's 2018 payment of $28,367 per procedure and the payer-negotiated device prices of $28,178 to $60,845 that nine top ear, nose and throat hospitals disclosed. A self-pay price would add the surgeon, anesthesia and facility fees to the device, so ask the implant center for an itemized written estimate that names each billing party.
How much does Inspire cost with insurance?
It depends on the plan's deductible, coinsurance and out-of-pocket maximum. A 2025 analysis of commercial claims from 2014 to 2022 found a median out-of-pocket cost of $263 for the surgery, ranging from $0 to $1,523. Sleep Foundation estimates about $2,000 to $6,000 for a Traditional Medicare patient without a supplement.
Is there a BMI limit for Inspire coverage?
Medicare's contractors require a BMI under 35, and the claim has to carry a matching Z68 code. The FDA label carries a BMI warning at 40 since June 2023, and Aetna's policy uses BMI under 40. Inspire's coverage page states both numbers. Whether a particular BMI fits is checked at the evaluation, and the implant center will use the payer's current rule.
Does insurance cover the battery replacement?
The public policies cited here address the initial implant. Replacement is a separate procedure, coded CPT 64583, in a future plan year with that year's cost sharing. Ask the insurer in writing how it handles generator replacement, and ask the implant center what it has seen with your plan.
Does the VA cover Inspire?
Inspire lists the Department of Veterans Affairs among the payers that cover the therapy. Access runs through the treating VA facility's referral pathway, and cost sharing follows the veteran's priority group. Veterans in priority group 1 pay no copays for VA care; other groups pay the published VA copay for specialty care.
Is Inspire cheaper than CPAP over time?
This page does not compare the two treatments, and their costs fall on different schedules: CPAP is equipment, supplies and compliance-linked rental payments over years, while the implant is a surgical episode plus follow-up visits and a generator replacement roughly every 10 years. Which treatment fits a person is a clinical decision, not a price decision.
Is Inspire better than CPAP?
This page does not answer that question, and no cost figure can. Which treatment fits a person depends on the diagnosis, severity, anatomy, PAP history and overall health, and that judgment belongs to the treating sleep physician and surgeon. Our candidacy guide explains the gates an implant evaluation checks.
Is drug-induced sleep endoscopy covered?
The Medicare LCD and the Aetna policy both require a DISE finding before the implant, so the endoscopy is part of the coverage pathway, but it is billed as its own procedure with its own cost sharing. Ask how it is covered when prior authorization for the implant is requested.
Authoritative sources
Review the public guidance
- Inspire Medical Systems, Cost and Insurance
- Inspire Medical Systems, Frequently Asked Questions
- CMS Local Coverage Determination L38385, Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea (Novitas Solutions, New Jersey and Pennsylvania)
- CMS Local Coverage Determination L38307, Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea (CGS Administrators, revised effective March 5, 2026)
- CMS Billing and Coding Article A57149, Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
- CMS fact sheet, 2026 Medicare Parts A and B Premiums and Deductibles, November 14, 2025
- Medicare.gov, Outpatient hospital services
- Sleep Foundation, Does Medicare Cover Inspire? Updated January 28, 2026
- Aetna Clinical Policy Bulletin 0004, Obstructive Sleep Apnea in Adults
- Inspire Medical Systems press release, FDA approval for AHI indication expansion and increased BMI labeling, June 9, 2023
- Rathi VK et al., Use and Cost of a Hypoglossal Nerve Stimulator Device for Obstructive Sleep Apnea Between 2015 and 2018, JAMA Otolaryngology-Head & Neck Surgery, 2019 (PMC6707009)
- Payer-negotiated pricing of the hypoglossal nerve stimulator, Journal of Clinical Sleep Medicine, 2022 (PMC9435329)
- Out-of-Pocket Costs and Surprise Billing in Otolaryngology: A National Database Analysis, Otolaryngology-Head and Neck Surgery, 2025 (PMC12661487)
- U.S. Department of Veterans Affairs, Cost of VA health care
Written by the Modern Sleep & Metabolic Institute editorial team. Published September 18, 2026. Domenico Savatta, MD, FACS has not yet reviewed this page; clinical review has been requested, and the review date will appear here once complete. Source links support education, not a personal recommendation.
